Endoscopic Ultrasound Market to grow with a CAGR of 7.21 % through 2029

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the Global Endoscopic Ultrasound Market in the forecast period 2025-2029

According to TechSci Research report, “Endoscopic Ultrasound Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2019-2029”, Global Endoscopic Ultrasound Market was valued at USD 1.44 billion in 2023 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 7.21% through 2029.

Collaborations and partnerships among leading companies play a pivotal role in consolidating expertise and bolstering market positions. The increasing aging population is a key driver of demand for endoscopic ultrasound (EUS). As individuals age, they become more susceptible to a range of age-related ailments, including gastrointestinal cancers, pancreatic diseases, and pulmonary conditions. These conditions often necessitate diagnostic procedures such as EUS for precise assessment, diagnosis, and staging. Many diseases commonly diagnosed and staged using EUS, such as pancreatic cancer, lung cancer, and gastrointestinal malignancies, exhibit higher prevalence rates among older demographics. Consequently, the aging population drives the demand for EUS procedures. Elderly individuals often present with complex health profiles, necessitating precise and minimally invasive diagnostic and therapeutic interventions. EUS serves as an invaluable tool for healthcare providers in conducting comprehensive assessments and tailoring treatment strategies for older patients. Given that older adults may have comorbidities, EUS aids in accurately assessing disease stages, crucial for evaluating the risks and benefits of various treatment modalities. This personalized approach holds particular significance for older patient cohorts.

Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " Global Endoscopic Ultrasound Market”

Patient acceptance and awareness pose challenges in the global Endoscopic Ultrasound (EUS) market. Despite being minimally invasive compared to traditional surgical methods, some patients perceive EUS procedures as invasive, which can deter acceptance. Concerns about discomfort or pain during the procedure contribute to patient hesitancy. Additionally, many patients lack familiarity with EUS and its potential benefits, leading to a lack of interest in seeking it as a diagnostic or therapeutic option. Anxiety or apprehension may arise, particularly among patients who have not received sufficient information or have concerns about the process. The technical aspects and medical terminology associated with EUS can further complicate patient understanding. Effective communication by healthcare providers regarding the procedure's purpose and benefits in clear and understandable language is crucial. Education about the value of EUS in diagnosing and treating various medical conditions is essential for both patients and referring physicians to address knowledge gaps that impact patient acceptance. Comfort and a positive experience are priorities for patients undergoing medical procedures. Therefore, healthcare providers must ensure that EUS procedures are well-tolerated and as comfortable as possible for patients.

Global Endoscopic Ultrasound Market is segmented based on By Product, Application, End-use, and by region.

Based on application, the Global Endoscopic Ultrasound (EUS) Market largest share was held by Lung cancer segment and is predicted to continue expanding over the coming years.  Lung cancer is one of the most common and deadly forms of cancer worldwide. The high incidence of lung cancer drives the demand for accurate diagnosis, staging, and treatment planning, all of which can be facilitated by EUS. EUS is a valuable tool for diagnosing and staging lung cancer. It provides detailed images of lung lesions and nearby lymph nodes, allowing healthcare professionals to assess the extent of the disease, determine its operability, and plan appropriate treatment strategies. EUS is a minimally invasive procedure, which is particularly important for lung cancer patients. It enables the collection of tissue samples (fine-needle aspiration) and the assessment of lesions without the need for more invasive surgical procedures, reducing patient discomfort and recovery time. EUS can guide transbronchial needle aspirations (TBNA) and other minimally invasive interventions for lung cancer patients. This approach allows for more accurate biopsies and staging, contributing to better patient outcomes. EUS offers high-resolution, real-time imaging that is essential for assessing lung lesions and making critical decisions regarding patient care.

Based on Region, North America held the largest share in the Global Endoscopic Ultrasound Market. The healthcare reimbursement systems in North America, particularly in the United States, historically offer favorable coverage for Endoscopic Ultrasound (EUS) procedures. This incentivizes healthcare providers to include EUS as a viable diagnostic and therapeutic option. Many prominent medical device manufacturers and healthcare institutions involved in EUS research and development are based in North America. This fosters innovation and advancement in EUS technologies and practices within the region. Patients in North America typically possess a high level of awareness regarding healthcare options and may request EUS procedures as needed, further stimulating demand. Competition among medical device manufacturers and healthcare providers in North America drives the development of enhanced and more accessible EUS technologies and services.

Some of the major companies operating in the Global Endoscopic Ultrasound Market include:

• Boston Scientific Corporation
• Medtronic Plc.
• ConMed Corp.
• Olympus Corporation
• STERIS
• SonoScape Medical Corp.
• PENTEX Medical 
• FUJIFILM Corporation
• Cook Group Incorporated

Download Free Sample Report

Customers can also request for 10% free customization on this report

“The endoscopic ultrasound market is set for sustained growth as healthcare providers increasingly acknowledge its efficacy in diagnosing and treating various gastrointestinal and pancreaticobiliary disorders. Ongoing investment in research and development, coupled with initiatives to improve the accessibility and affordability of EUS procedures, will be instrumental in driving market expansion and enhancing patient outcomes", said Mr. Karan Chechi, Research Director of TechSci Research, a research-based Global management consulting firm.

"Endoscopic Ultrasound Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Needle, Endoscope, Ultrasound Probe, Accessories, Ultrasonic Processors), By Application (Gastrointestinal Cancer, Lung Cancer, Pancreaticobiliary Disease, others), By End-use (Hospitals & Clinics, Ambulatory Surgical Centers, others), By Region, and Competition, 2019-2029F", has evaluated the future growth potential of Global Endoscopic Ultrasound Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Endoscopic Ultrasound Market.

Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]

Website: www.techsciresearch.com